Jonathan Milner, Co-Founder & CEO of Abcam talks at LBS.
Jonathan Milner was a research fellow at Cambridge when he developed the idea for Abcam, in what he describes as an 'entrepreneurial seizure'. Frustrated by the lack of available antibodies to undertake his research, Jonathan decided a one-stop shop where all the world's antibodies could be sourced would transform his and other researcher's efficiency. Abcam was founded in 1998. In the summer of 2010 Business Weekly named Abcam as Business of the Year and predicted it would 'jet straight into the FTSE 250' with a market cap of £600M.
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?